A compound of Formula I, which possesses 5-HT2A and/or 5-HT2c selective receptor activity, but lacks at least some of the undesirable characteristics of 5-HT2B-agonist related activities, is disclosed. Methods of preparing said compounds are also described. The compound of Formula I may be useful in the treatment of depression, alcoholism, tobacco and cocaine addiction, inflammation, cluster headache, PTSD, seizure disorders and other CNS disorders.
公开了一种具有5-HT2A和/或5-HT2c选择性受体活性但缺乏至少一些不良特性的5-HT2B激动剂相关活性的化合物I的化合物。还描述了制备所述化合物的方法。化合物I的化合物可能在治疗抑郁症、
酒精中毒、吸烟和
可卡因成瘾、炎症、集群头痛、创伤后应激障碍、癫痫和其他中枢神经系统疾病方面有用。